Reauthorize the C.W. Bill Young Cell Transplantation Program at $33 million annually for five years and the National Cord Blood Inventory at $23 million annually for five years.

Gus M. Bilirakis · Florida · Republican

spending impact 0.72 specificity 0.93 extraction confidence 90%

Contest this claim

Occurrences

Specifically, the bill would: Reauthorize the C.W. Bill Young Cell Transplantation Program at $33 million annually for five years; Reauthorize the National Cord Blood Inventory at $23 million annually for five years.

Bilirakis co-introduces legislation to continue federal funding for cord blood and bone marrow transplant programs for five more years.

Bipartisan Bill Introduced to Reauthorize National Cord Blood and Bone Marrow Transplant Programs | Congressman Gus Bilirakis
primary · press_release · model gpt-5.4-mini

Evidence

The enacted law reauthorized the C.W. Bill Young Cell Transplantation Program and extended funding authority through fiscal years 2016-2020, but it set the authorization at $30,000,000 annually for the program and $23,000,000 annually for the National Cord Blood Inventory.

This is concrete follow-through on the underlying policy, but it does not match the promised $33 million for the program; it matches the cord blood figure and five-year span. Best read as partial delivery rather than full delivery.

partial unknown A for effort

Public Law 114-104, Stem Cell Therapeutic and Research Reauthorization Act of 2015
secondary · model gpt-5.4-mini · confidence 96%

Contest this evidence item

Assessments

partial same_term

Congress enacted a reauthorization covering the promised five-year span and preserved the National Cord Blood Inventory at the promised $23 million annually, but the C.W. Bill Young Cell Transplantation Program was authorized at $30 million annually rather than the promised $33 million. That is substantial but incomplete delivery of the specific funding promise, so full credit is not warranted.

provider codex_cli · model gpt-5.4 · confidence 94%